Sanofi lays out €40M to beef up transplant, diabetes drug production in France

With several high-profile manufacturing outlays already in the books in Europe this year, Sanofi is returning to the bloc in a bid to boost production for a long-approved transplant treatment and a relatively new Type 1 diabetes drug.